The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

ACE  -  angiotensin I converting enzyme (peptidyl...

Canis lupus familiaris

This record was replaced with 610668.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of ACE


Psychiatry related information on ACE


High impact information on ACE


Chemical compound and disease context of ACE


Biological context of ACE


Anatomical context of ACE


Associations of ACE with chemical compounds


Other interactions of ACE


Analytical, diagnostic and therapeutic context of ACE


  1. The renin-angiotensin system during acute myocardial ischemia in dogs. Santos, R.A., Brum, J.M., Brosnihan, K.B., Ferrario, C.M. Hypertension (1990) [Pubmed]
  2. Ro 42-5892 is a potent orally active renin inhibitor in primates. Fischli, W., Clozel, J.P., el Amrani, K., Wostl, W., Neidhart, W., Stadler, H., Branca, Q. Hypertension (1991) [Pubmed]
  3. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Noda, K., Sasaguri, M., Ideishi, M., Ikeda, M., Arakawa, K. Cardiovasc. Res. (1993) [Pubmed]
  4. Blockade of the renin-angiotensin system in heart failure in conscious dogs. Murakami, M., Suzuki, H., Naitoh, M., Matsumoto, A., Kageyama, Y., Tsujimoto, G., Saruta, T. J. Hypertens. (1995) [Pubmed]
  5. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Hayashida, W., Donckier, J., Van Mechelen, H., Charlier, A.A., Pouleur, H. Cardiovasc. Res. (1997) [Pubmed]
  6. Brain renin. Inagami, T., Clemens, D.L., Hirose, S., Okamura, T., Naruse, K., Takii, Y., Yokosawa, H. Clinical and experimental hypertension. Part A, Theory and practice. (1982) [Pubmed]
  7. Evaluation of survival rate and prognostic indicators for surgical treatment of left-to-right patent ductus arteriosus in dogs: 52 cases (1995-2003). Bureau, S., Monnet, E., Orton, E.C. J. Am. Vet. Med. Assoc. (2005) [Pubmed]
  8. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. Dell'Italia, L.J., Meng, Q.C., Balcells, E., Wei, C.C., Palmer, R., Hageman, G.R., Durand, J., Hankes, G.H., Oparil, S. J. Clin. Invest. (1997) [Pubmed]
  9. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. Clavell, A.L., Mattingly, M.T., Stevens, T.L., Nir, A., Wright, S., Aarhus, L.L., Heublein, D.M., Burnett, J.C. J. Clin. Invest. (1996) [Pubmed]
  10. Inhibition of angiotensin-converting enzyme by perindopril diacid in canine oleic acid pulmonary edema. Leeman, M., Lejeune, P., Naeije, R. Crit. Care Med. (1987) [Pubmed]
  11. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors. Kivlighn, S.D., Zingaro, G.J., Gabel, R.A., Broten, T.P., Chang, R.S., Ondeyka, D.L., Mantlo, N.B., Gibson, R.E., Greenlee, W.J., Siegl, P.K. Eur. J. Pharmacol. (1995) [Pubmed]
  12. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs. Vollmer, R.R., Boccagno, J.A., Harris, D.N., Murthy, V.S. Eur. J. Pharmacol. (1978) [Pubmed]
  13. Effects of enalaprilat on the renin-angiotensin-aldosterone system and on renal function during CO2 pneumoperitoneum. Borba, M.R., Lopes, R.I., Carmona, M., Neto, B.M., Nahas, S.C., Pereira, P.R. J. Endourol. (2005) [Pubmed]
  14. Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock. Morton, J.J., Semple, P.F., Ledingham, I.M., Stuart, B., Tehrani, M.A., Garcia, A.R., McGarrity, G. Circ. Res. (1977) [Pubmed]
  15. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Münzel, T., Bassenge, E. Circulation (1996) [Pubmed]
  16. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure. Sweet, C.S., Ludden, C.T., Frederick, C.M., Ribeiro, L.G. Am. J. Med. (1984) [Pubmed]
  17. Comparison of renin and converting enzyme inhibition in sodium-deficient dogs. Blaine, E.H., Nelson, B.J., Seymour, A.A., Schorn, T.W., Sweet, C.S., Slater, E.E., Nussberger, J., Boger, J. Hypertension (1985) [Pubmed]
  18. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs. Harris, D.N., Heran, C.L., Goldenberg, H.J., High, J.P., Laffan, R.J., Rubin, B., Antonaccio, M.J., Goldberg, M.E. Eur. J. Pharmacol. (1978) [Pubmed]
  19. Treatment with enalapril fails to prevent impaired cardiopulmonary baroreflex control in dogs with left ventricular dysfunction. Kinugawa, T., Dibner-Dunlap, M.E., Sica, D.A., Thames, M.D. J. Card. Fail. (1995) [Pubmed]
  20. Vascular neuroeffector function in two-kidney, one clip hypertensive dogs. Toda, N., Miyazaki, M., Okamura, T. J. Hypertens. (1985) [Pubmed]
  21. Effects of BIBR-277, an angiotensin II type 1 receptor antagonist, on stunned myocardium in dogs. Izumi, H., Nakai, T., Kano, S., Hoshi, K., Ichihara, K. Coron. Artery Dis. (1996) [Pubmed]
  22. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury. Miyazaki, M., Wada, T., Shiota, N., Takai, S. Journal of human hypertension. (1999) [Pubmed]
  23. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. Gammelgaard, I., Wamberg, S., Bie, P. Acta physiologica (Oxford, England) (2006) [Pubmed]
  24. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Clappison, B.H., Anderson, W.P., Johnston, C.I. Kidney Int. (1981) [Pubmed]
  25. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications. Chan, D.P., Clavell, A., Keiser, J., Burnett, J.C. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. (1994) [Pubmed]
  26. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure. Cataliotti, A., Boerrigter, G., Chen, H.H., Jougasaki, M., Costello, L.C., Tsuruda, T., Lee, S.C., Malatino, L.S., Burnett, J.C. Circulation (2002) [Pubmed]
  27. Effect of acute smoke inhalation on angiotensin converting enzyme, plasminogen activator, and angiotensin-II in the dog. Clark, W.R., Molteni, A., Nieman, G., Brizio-Molteni, L., Solliday, N.H. Ann. Clin. Lab. Sci. (1989) [Pubmed]
  28. Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog. Navar, L.G., LaGrange, R.A., Bell, P.D., Thomas, C.E., Ploth, D.W. Hypertension (1979) [Pubmed]
  29. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction. de Gusmão, F.M., Becker, C., Carvalho, M.H., Barros, L.F. International journal of cardiology. (2005) [Pubmed]
  30. Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models. Inada, Y., Tanabe, M., Shibouta, Y., Kawazoe, K., Nishikawa, K., Kikuchi, S. Jpn. J. Pharmacol. (1986) [Pubmed]
  31. Effects of angiotensin II type 1 receptor antagonist (candesartan) in preventing fatal ventricular arrhythmias in dogs during acute myocardial ischemia and reperfusion. Hiura, N., Wakatsuki, T., Yamamoto, T., Nishikado, A., Oki, T., Ito, S. J. Cardiovasc. Pharmacol. (2001) [Pubmed]
  32. ACE inhibition prevents Na and water retention and MABP increase during reduction of renal perfusion pressure. Boemke, W., Seeliger, E., Rothermund, L., Corea, M., Pettker, R., Mollenhauer, G., Reinhardt, H.W. Am. J. Physiol. (1995) [Pubmed]
WikiGenes - Universities